Literature DB >> 12239209

Calcineurin and NFAT4 induce chondrogenesis.

Masuhiro Tomita1, Martina I Reinhold, Jeffery D Molkentin, Michael C Naski.   

Abstract

Nuclear factor of activated T-cells (NFAT) and calcineurin are essential regulators of immune cell and mesenchymal cell differentiation. Here we show that elevated intracellular calcium induces chondrogenesis through a calcineurin/NFAT signaling axis that activates bone morphogenetic protein (BMP) expression. The calcium ionophore, ionomycin, induced chondrogenesis through activation of calcineurin. The calcineurin substrate, NFAT4, also induced chondrogenesis and chondrocyte gene expression. Significantly, the BMP antagonist, noggin, or dominant negative BMP receptors blocked the effects of elevated intracellular calcium on chondrogenesis. This suggested that calcineurin/NFAT4 activates BMP expression. Consistent with this, BMP2 gene expression was increased by ionomycin and suppressed by the calcineurin inhibitor, cyclosporine A. Furthermore, activated NFAT4 induced BMP2 gene expression. These results have important implications for the effects of NFATs during development and adaptive responses.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12239209     DOI: 10.1074/jbc.C200504200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

Review 1.  Regulation of chondrogenesis and chondrocyte differentiation by stress.

Authors:  Michael J Zuscik; Matthew J Hilton; Xinping Zhang; Di Chen; Regis J O'Keefe
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

2.  Bmp signaling represses Vegfa to promote outflow tract cushion development.

Authors:  Yan Bai; Jun Wang; Yuka Morikawa; Margarita Bonilla-Claudio; Elzbieta Klysik; James F Martin
Journal:  Development       Date:  2013-07-17       Impact factor: 6.868

3.  Low Molecular Weight Fraction of Commercial Human Serum Albumin Induces Morphologic and Transcriptional Changes of Bone Marrow-Derived Mesenchymal Stem Cells.

Authors:  David Bar-Or; Gregory W Thomas; Leonard T Rael; Elizabeth D Gersch; Pablo Rubinstein; Edward Brody
Journal:  Stem Cells Transl Med       Date:  2015-06-03       Impact factor: 6.940

4.  Nfatc2 is a primary response gene of Nell-1 regulating chondrogenesis in ATDC5 cells.

Authors:  Weiwei Chen; Xinli Zhang; Ronald K Siu; Feng Chen; Jia Shen; Janette N Zara; Cymbeline T Culiat; Sotirios Tetradis; Kang Ting; Chia Soo
Journal:  J Bone Miner Res       Date:  2011-06       Impact factor: 6.741

5.  WNT5A regulates chondrocyte differentiation through differential use of the CaN/NFAT and IKK/NF-kappaB pathways.

Authors:  Elizabeth W Bradley; M Hicham Drissi
Journal:  Mol Endocrinol       Date:  2010-06-23

6.  Cyclosporine A-induced renal fibrosis: a role for epithelial-mesenchymal transition.

Authors:  Craig Slattery; Eric Campbell; Tara McMorrow; Michael P Ryan
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

7.  Systemic and local ACTH produced during inflammatory states promotes osteochondrogenic mesenchymal cell differentiation contributing to the pathologic progression of calcified atherosclerosis.

Authors:  Jodi F Evans; Louis Ragolia
Journal:  Med Hypotheses       Date:  2012-09-29       Impact factor: 1.538

8.  Cav3.2 T-type calcium channel is required for the NFAT-dependent Sox9 expression in tracheal cartilage.

Authors:  Shin-Shiou Lin; Bing-Hsiean Tzeng; Kuan-Rong Lee; Richard J H Smith; Kevin P Campbell; Chien-Chang Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

9.  The effect of oxygen tension on calcium homeostasis in bovine articular chondrocytes.

Authors:  Rachel White; John S Gibson
Journal:  J Orthop Surg Res       Date:  2010-04-26       Impact factor: 2.359

10.  ACTH promotes chondrogenic nodule formation and induces transient elevations in intracellular calcium in rat bone marrow cell cultures via MC2-R signaling.

Authors:  Jodi F Evans; Sylvana Rodriguez; Louis Ragolia
Journal:  Cell Tissue Res       Date:  2013-01-29       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.